The largest database of trusted experimental protocols

Vwf antibody

Manufactured by Agilent Technologies
Sourced in Denmark

The VWF antibody is a laboratory reagent used to detect and measure the levels of von Willebrand factor (VWF) in biological samples. VWF is a large glycoprotein involved in blood clotting and platelet adhesion. The VWF antibody can be used in various analytical techniques, such as ELISA, Western blotting, and immunohistochemistry, to quantify VWF concentrations or assess its distribution and localization in cells and tissues.

Automatically generated - may contain errors

5 protocols using vwf antibody

1

Quantification of Megakaryocytes in Bone Niches

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen was processed as described and sections were stained with an anti-B220 antibody [39] (link). Femur sections were stained with a rabbit polyclonal anti-von Willebrand Factor (vWF) antibody from Dako. For quantification of megakaryocytes in osteoblastic and vascular niches, the whole diaphysis of three consecutive femur sections was scanned with a conventional microscope (20× objective) for vWF+ cells, as described [40] (link). Megakaryocytes in the osteoblastic niche were calculated as the number of megakaryocytes in contact with the endosteal border. Megakaryocytes in the vascular niche were calculated as the number of megakaryocyte per vessel border. Osteoblastic and vascular borders were calculated with ImageJ software. Results are means ± SEM of 3 mice per genotype.
+ Open protocol
+ Expand
2

Histological, Immunohistochemical, and Biochemical Markers of Bile Duct Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Histological signs of bile duct injury were assessed by an established scoring system, as described by op den Dries et al.9 (link) In addition, immunohistochemistry for von Willebrand factor (VWF) was performed to determine peribiliary vascular density of both intrahepatic and extrahepatic bile ducts. VWF antibody (Dako, Glostrup, Denmark) was applied to deparaffinized slides in a dilution of 1:250 according to the manufacturer’s instructions. Arterioles of the PVP that were positively stained for VWF were counted at a magnification of ×20, and the mean of 5 fields per slide was used to calculate the vascular density score. All histological assessments were performed by 2 independent investigators (YdV and IMAB), who were blinded for the perfusion group and supervised by an experienced hepato-pathologist (ASHG).
In addition, lactate dehydrogenase (LDH) concentration in bile samples was determined as a marker of biliary epithelial cell death.18 (link) Biliary pH, bicarbonate, and glucose were used as established biomarkers of biliary injury and function.19 (link)
+ Open protocol
+ Expand
3

Angiogenesis and Lymphangiogenesis in Muscle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were sacrificed at 7 days after surgery and thigh adductor muscles of the legs were removed, fixed in 10% formaldehyde solution, and paraffin embedded. Muscle fiber numbers were measured in sections stained with hematoxylin and eosin, and the mean counts from five separate fields in four distinct areas from each specimen were calculated. Capillary endothelial cells were identified by immunohistochemical staining with von Willebrand factor (vWF) antibody (Dako, Glostrup, Denmark). Capillary density was expressed as the ratio of vWF positive cells to myofibers per high power field (hpf) (magnification, ×400). Furthermore, lymphangiogenesis was assessed using the lymphatic vessel endothelial hyaluronan receptor (LYVE)-1 antibody (Relia Tech GmbH, Wolfenbüttel, Germany).
+ Open protocol
+ Expand
4

Vascular Inflammation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cadmium granules, potassium nitrate, bovine thrombin, sodium chloride, calcium chloride, lipopolysaccharide (LPS, from Escherichia coli serotype 026: B6), trichloroacetic acid, trizma base, sulphorhodamine B, 3′diaminobenzidine, HEPES, and other reagents were purchased from Sigma Aldrich, USA. Avidin peroxidase and streptAvidin peroxidase, anti-VCAM-1, anti-ICAM-1, anti-E-Selectin antibodies were obtained from Santa Cruz Biotechnology, USA. 3,3′,5,5′-tetramethylbenzidine (TMB) was purchased from Scyteck, USA. Chromogenic substrates from Chromogenix AB, Italy. Plasmin, uPA and double chain tPA standards (tcu-PA) were obtained from Sekisui, USA. Mouse IL-6 minikit and mouse TNF-α minikit, recombinant mouse TNF-α were purchased from Thermo Scientific, USA. Fetal bovine serum from Gibco, BRL, USA. vWF antibody from DAKO, USA. Murine TF standard were obtained from R&D Systems, USA.
+ Open protocol
+ Expand
5

Monoclonal Antibodies Inhibit Tumor Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
1×106 143B cells were mixed with 500 μg 10H10, 5G9 (mouse monoclonal antibodies against TF) or a control mouse IgG in PBS and injected subcutaneously (n=6) in NOD-SCID mice (Jackson Laboratories, Westgrove, PA, USA). Tumor growth was measured over time using calipers; tumor volume was calculated as width2 * length * 0.5. Tumors were harvested after 3 weeks and formalin-fixed, paraffin-embedded for further analysis. Lungs were snap-frozen in liquid nitrogen. Animal experiments were approved by the animal ethical committee of the Leiden University Medical Center. Immunohistochemsirty was performed as described above, a vWF antibody (1:5000, DAKO, Glostrup, Denmark) was used to stain microvessels. Ki67 (1:800, DAKO, Glostrup, Denmark) was used to proliferating cells. Ki67 positive nuclei were quantified as described by Tuominen et al.(23 (link)) Microvessel density was quantified by counting vWF+ microvessels in at least two fields per tumor at 10× magnification. Means were calculated, a t-test was performed to determine statistical significance between IgG control and 10H10 or 5G9 groups.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!